EUVIMEDScopri EUVIMED
Crossref

Phage Selection of Cyclic Peptides Inhibiting Aminoglycoside Phosphotransferases to Control Resistant Bacteria

Qiannan Guo, Hui Zeng, Xu-Dong Kong iD

ACS Chemical Biology · 2025

DOI: 10.1021/acschembio.5c00366 ↗

At a glance

Journal article in ACS Chemical Biology, 2025. Written by Qiannan Guo and 2 co-authors. Institution: State Key Laboratory of Microbial Metabolism, School of Life Sciences & Biotechnology, and Zhangjiang Institute for Advanced Study, Shanghai Jiao Ton…. Major MEDLINE topics: Peptides, Cyclic, Peptide Library, Anti-Bacterial Agents, Escherichia coli. 38 references. Funded by: Ministry of Science and Technology of the People's Republic of China, Science and Technology Commission of Shanghai Municipality, National Natural Science Foundation of China.

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

The clinical threat of aminoglycoside phosphotransferases (APHs) stems from their efficient inactivation of aminoglycosides, driving multidrug resistance through broad-spectrum antibiotic modification. While peptide-based inhibitors represent a promising therapeutic modality, current candidates lack sufficient potency against APHs. To address this limitation, we employed phage display technology to screen large cyclic peptide libraries (structural diversity >1011) against APH(3')-Ia, a clinically relevant enzyme derived from Escherichia coli. Our selection identified cyclic peptide families exhibiting nanomolar binding affinities characterized by two conserved motifs: CXW(P/L)LC and CP(W/F)YC. Intriguingly, divalent cations (Mg2+ and Ca2+) enhanced peptide-APH interactions, suggesting a metal-dependent binding mechanism. Competitive fluorescence polarization assays revealed that these cyclic peptides primarily occupy the ATP-binding pocket of APH(3')-Ia, with representative candidate A-L3 demonstrating significant enzymatic inhibition. This study establishes a foundation for developing APH-targeted antibiotic adjuvants through (1) identification of novel cyclic peptide scaffolds with inhibitory potential, (2) elucidation of divalent metal ion effects on inhibitor binding, and (3) mechanistic insights into ATP-binding site competition. These findings provide critical structural and functional information to guide the rational design of next-generation antibiotic resistance breakers.

Subjects

MeSH terms (MEDLINE)

Peptides, CyclicPeptide LibraryAnti-Bacterial AgentsEscherichia coliKanamycin KinaseEnzyme InhibitorsDrug Resistance, Bacterial

Substances

Peptides, CyclicPeptide LibraryAnti-Bacterial AgentsKanamycin KinaseEnzyme Inhibitors

Authors and institutions

  • State Key Laboratory of Microbial Metabolism, School of Life Sciences & Biotechnology, and Zhangjiang Institute for Advanced Study, Shanghai Jiao Tong University, 800 Dongchuan Road, Shanghai 200240, China.

ORCID profiles: Xu-Dong Kong

Funding

  • Ministry of Science and Technology of the People's Republic of China
  • Science and Technology Commission of Shanghai Municipality
  • National Natural Science Foundation of China

Cite

APA

Guo, Q., Zeng, H., & Kong, X. D. (2025). Phage Selection of Cyclic Peptides Inhibiting Aminoglycoside Phosphotransferases to Control Resistant Bacteria. ACS Chemical Biology. https://doi.org/10.1021/acschembio.5c00366

Vancouver

Guo Q, Zeng H, Kong XD. Phage Selection of Cyclic Peptides Inhibiting Aminoglycoside Phosphotransferases to Control Resistant Bacteria. ACS Chemical Biology. 2025. doi:10.1021/acschembio.5c00366

BibTeX
@article{Guo2025,
  author = {Guo, Qiannan and Zeng, Hui and Kong, Xu-Dong},
  title = {Phage Selection of Cyclic Peptides Inhibiting Aminoglycoside Phosphotransferases to Control Resistant Bacteria},
  journal = {ACS Chemical Biology},
  year = {2025},
  doi = {10.1021/acschembio.5c00366}
}
Start for free →